Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kosaku OHNO
3. Development of Pharmacological Chaperone Therapy for Neuronopathic Gaucher Disease
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Arimoclomol as a Potential Therapy for Neuronopathic Gaucher Disease
Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria
Scientific Reports
Multidisciplinary
AB120. Cholelithiasis in a Filipino Child With Chronic Neuronopathic Gaucher Disease: Report of a Case
Annals of Translational Medicine
Medicine
Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
PP044 Adherence to Enzyme Replacement Therapy in Gaucher Disease
International Journal of Technology Assessment in Health Care
Health Policy
Three Classes of Glucocerebrosidase Inhibitors Identified by Quantitative High-Throughput Screening Are Chaperone Leads for Gaucher Disease
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chitinase in Humans Is a Marker for Gaucher Disease. Potential for Monitoring Therapy. 850
Pediatric Research
Child Health
Pediatrics
Perinatology
Structural Development Study of a Novel Pharmacological Chaperone for Folding-Defective Rhodopsin Mutants Responsible for Retinitis Pigmentosa
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science